Co-Diagnostics IncNASDAQ:CODX
No Matches were found for
- LAST PRICE1.0500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.0300/ 20
- Ask / Lots1.1300/ 13
- Open / Previous Close1.0512 / 1.0500
- Day Range
- 52 Week Range
- Volume32,514
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CODX |
|---|---|---|
| 09:32 ET | 158 | 1.0512 |
| 09:34 ET | 200 | 1.06 |
| 09:36 ET | 100 | 1.04 |
| 09:43 ET | 1600 | 1.05 |
| 10:15 ET | 100 | 1.05 |
| 10:17 ET | 200 | 1.059 |
| 10:28 ET | 100 | 1.06 |
| 10:30 ET | 100 | 1.06 |
| 10:33 ET | 1008 | 1.07 |
| 10:42 ET | 561 | 1.0588 |
| 11:11 ET | 203 | 1.07 |
| 11:22 ET | 10000 | 1.08 |
| 11:24 ET | 100 | 1.09 |
| 11:26 ET | 1000 | 1.09 |
| 11:38 ET | 100 | 1.0808 |
| 11:40 ET | 1829 | 1.0995 |
| 11:56 ET | 167 | 1.1 |
| 12:05 ET | 500 | 1.08 |
| 12:12 ET | 125 | 1.0812 |
| 12:23 ET | 2000 | 1.0949 |
| 12:27 ET | 300 | 1.09 |
| 12:45 ET | 100 | 1.09 |
| 01:01 ET | 300 | 1.08 |
| 01:08 ET | 110 | 1.09 |
| 01:28 ET | 200 | 1.06 |
| 01:51 ET | 200 | 1.06 |
| 02:06 ET | 500 | 1.0535 |
| 02:24 ET | 400 | 1.07 |
| 02:27 ET | 215 | 1.08 |
| 03:14 ET | 352 | 1.06 |
| 03:18 ET | 100 | 1.05 |
May 13, 2024
DJ Co-Diagnostics Is Maintained at Neutral by HC Wainwright & Co., from 7:17AM ET on Monday May 13, 2024 by Dow Jones
7:17AM ET on Monday May 13, 2024 by Dow Jones
May 9, 2024
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow Jones*DJ Co-Diagnostics 1Q Loss/Shr 31c >CODX, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Co-Diagnostics Inc | 32.8M | -0.8x | --- |
Renalytix PLC | 32.4M | -0.5x | --- |
Neuroone Medical Technologies Corp | 25.6M | -1.6x | --- |
Akili Inc | 33.1M | -0.7x | --- |
Medite Cancer Diagnostics Inc | 8.7K | 0.0x | --- |
Avinger Inc | 3.7M | -0.1x | --- |
Company Information
No data available
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $32.8M |
|---|---|
Revenue (TTM) | $6.7M |
Shares Outstanding | 31.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.85 |
EPS | $-1.32 |
Book Value | $2.75 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | 4.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -636.57% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
